Evidence map›Paper›PMID 14725353›Full record

ArticlePharmaceutical research2003

Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1.

Tomomi Uchiyama, Ashutosh A Kulkarni, Daryl L Davies, Vincent H L Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tomomi UchiyamaDepartment of Pharmaceutical Sciences, University of Southern California, 1985 Zonal Ave., Los Angeles, CA 90089-9121, USA.
Ashutosh A Kulkarni
Daryl L Davies
Vincent H L Lee
University of Southern California · US

Funding

USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GOLDEN, LUCY MARY · 1995 to 2020
$21.8M
PEPT1: STRUCTURE-FUNCTION, SORTING AND MODULATIONR01GM059297 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAWORTH, IAN S · 2000 to 2003
$1.3M
NIDDK NIH HHS 1P30 DK48522NIGMS NIH HHS GM59297
6 · The paper itself

Abstract

purposeThe objective of this study was to provide direct evidence of the relative importance of the His57 residue present in transmembrane domain 2 (TMD 2) and the His121 residue in TMD 4 as proton-binding sites in human PepT1 (hPepT1) by using a novel mutagenesis approach.

methodsHis57 and His121 in hPepT1 were each mutated to alanine, arginine, or lysine individually to obtain H57A-, H57R-, H57K-, H121A-, H121R-, and H121K-hPepT1. H7A-hPepT1 was used as a negative control. [3H]Glycylsarcosine (Gly-Sar) uptake was measured 72 h posttransfection using HEK293 cells individually transfected with these mutated proteins. Steady-state I/V curves (-150 mV to +50 mV, holding potential -70 mV) were obtained by measuring 5 mM Gly-Sar-induced currents in oocytes expressing H-57R- and H57K-hPepT1. Noninjected oocytes and wild-type hPepT1 (WT-hPepT1)-injected oocytes served as negative and positive controls, respectively.

resultsAt pH 6.0, H57K-, H57R-, H121K-, and H121R-hPepT1 led to a 97%, 90%, 45%, and 75% decrease in [3H]Gly-Sar uptake into HEK293 cells, respectively. At pH 7.4, uptake in cells transfected with H57K- and H57R-hPepT1 was not significantly different from that at pH 6.0, whereas cells expressing H121R- and H121K-hPepT1 showed 56% and 65% decrease, respectively, compared to that at pH 6.0. In oocytes expressing H57R-hPepT1, steady-state currents induced by 5 mM Gly-Sar increased with increasing pH (I(max) = 300 nA at pH 8.5), suggesting the binding of protons to H57R. No such trend was observed in oocytes injected with H57K, H121R, and H121K cRNA.

conclusionsH57R-hPepT1 is able to bind protons at a relatively basic pH, resulting in facilitation of transport of Gly-Sar by hPepT1 at higher pH. Our novel approach provides direct evidence that His57 is a principal proton-binding site in hPepT1.

Indexed as

SymportersAlgorithmsAnimalsArginineBinding SitesCarrier ProteinsElectrophysiologyHistidineHumansHydrogen-Ion ConcentrationIntestinal MucosaLysineMicroscopy, FluorescenceMutagenesis, Site-DirectedOocytesPatch-Clamp TechniquesArginineCarrier ProteinsHistidineLysinePeptide Transporter 1ProtonsRNASLC15A1 protein, humanSymporters

Identifiers

PMID14725353
OpenAlexW2026568713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.